In vivo formation of β-oxidized metabolites of leukotriene E4 in the rat

P. Perrin, J. Zirrolli, D. O. Stene, J. P. Lellouche, J. P. Beaucourt, R. C. Murphy

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Intraperitoneal administration of [3H]-leukotriene E4 in the rat resulted in the appearance of radiolabel in urine and feces. Separation of polar urinary metabolites and chromatographic comparison of synthetic metabolites indicated the in vivo formation of ω-oxidized metabolites of LTE4 with sequential β-oxidation. Futhermore, the metabolite identified as 16-carboxy-17,18,19,20-tetranor-14,15-dihydro-N-acetyl-LTE4 substantiates the biochemical patheway of β-oxidation in vivo involving the 2,4-dienoyl CoA reductase as an integral step. These results substantiate β-oxidation of sulfidopeptide leukotrienes in vivo and these metabolites account for some of the major urinary metabolites of this class of lipid mediator.

Original languageEnglish
Pages (from-to)53-60
Number of pages8
Issue number1
StatePublished - Jan 1989
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported, in part, by a grant from the National Institutes of Health (HL25785) and the Bourses de l’O.T.A.N., France. The authors wish to thank Dr. Eric Brass for preparation of the isolated hepatocytes used in these studies and Ms. Deborah Beckworth for preparation of this manuscript.


Dive into the research topics of 'In vivo formation of β-oxidized metabolites of leukotriene E4 in the rat'. Together they form a unique fingerprint.

Cite this